BioCentury
ARTICLE | Distillery Therapeutics

Enhancing SLC12A5 activity to treat refractory neonatal seizures

December 3, 2021 5:44 PM UTC

DISEASE CATEGORY: Neurology

INDICATION: Seizures...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article